March 10, 2014


Pharmaceutical Care Management Association (PCMA) President and CEO Mark Merritt issued the following statement on today’s letter from Centers for Medicare & Medicaid Services (CMS) Administrator Marilyn Tavenner to Congress on the proposed Part D rule:

“CMS was wise to reconsider its proposed Part D rule that would have destabilized the program, increased costs, and disrupted coverage for millions of seniors. While we welcome this temporary reprieve, we still await the final rule. However, today’s announcement appears to be a step in the right direction for Medicare Part D beneficiaries.”